About the journal
Glioma is an open-access journal published by Wolters Kluwer Medknow Publications in India, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wolters Kluwer Medknow Publications
- ISSN
- 2589-6113 · 2589-6121
- Country
- India
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 139
- Declared review time
- 20 weeks
- Declared peer-review model
- double_blind
- Official website
- https://journals.lww.com/tnoc/pages/default.aspx
Index listings
- DOAJ · 2019-01-28
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 20 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2024
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
139
Most recent article
2 years ago
Average review time (journal-declared via DOAJ)
20weeks
Works in OpenAlex
163
Last recorded publication year
2024
h-index
11
i10-index
11
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2024-08-08
- Added to DOAJ
- 2019-01-28
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Neuroblastoma Research and Treatments
- Meningioma and schwannoma management
Show all subjects (50)
- Neuroblastoma Research and Treatments
- Meningioma and schwannoma management
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Nanoplatforms for cancer theranostics
- Angiogenesis and VEGF in Cancer
- Nanoplatforms for cancer theranostics
- Angiogenesis and VEGF in Cancer
- Chromatin Remodeling and Cancer
- Histone Deacetylase Inhibitors Research
- Chromatin Remodeling and Cancer
- Immune cells in cancer
- Cancer Immunotherapy and Biomarkers
- Neurofibromatosis and Schwannoma Cases
- Ferroptosis and cancer prognosis
- CAR-T cell therapy research
- Histone Deacetylase Inhibitors Research
- Immune cells in cancer
- Neurofibromatosis and Schwannoma Cases
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Ferroptosis and cancer prognosis
- Brain Tumor Detection and Classification
- Management of metastatic bone disease
- Management of metastatic bone disease
- Mathematical Biology Tumor Growth
- Mathematical Biology Tumor Growth
- Brain Tumor Detection and Classification
- Neurogenesis and neuroplasticity mechanisms
- Medical Imaging Techniques and Applications
- Advanced MRI Techniques and Applications
- Neurogenesis and neuroplasticity mechanisms
- Medical Imaging Techniques and Applications
- Advanced MRI Techniques and Applications
Keywords (DOAJ)
- biotherapy
- chemotherapy
- glioma
- central nervous system tumours
- radiotherapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ